Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 18;8(12):e84586.
doi: 10.1371/journal.pone.0084586. eCollection 2013.

Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma

Affiliations

Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma

Mian Xi et al. PLoS One. .

Abstract

Purpose: To analyze the clinicopathological characteristics, treatment modalities, and potential prognostic factors of radiation-related second malignant neoplasms (SMNs) in a large group of nasopharyngeal carcinoma (NPC) cases.

Methods and materials: Institutional electronic medical records of 39,118 patients with NPC treated by definitive radiotherapy between February 1964 and December 2003 were reviewed. A total of 247 patients with confirmed SMN attributable to radiotherapy were included.

Results: Median latency between radiotherapy for NPC and the diagnosis of SMN was 9.5 years (range, 3.1-36.8 years). Squamous cell carcinoma was the most common histologic type, followed by fibrosarcoma and adenocarcinoma. Median progression-free survival and overall survival (OS) of the 235 patients who underwent treatment were 17.3 months and 28.5 months, respectively. The 5-year OS rates were 42.9%, 23.7%, and 0% for the surgery, radiotherapy, and chemotherapy groups, respectively. The independent prognostic factors associated with survival were sex, histologic type, and treatment modality in both the early stage subgroup and the advanced stage subgroup of SMN.

Conclusions: Sex, histologic type, and treatment modality were the significant prognostic factors for SMN. Complete resection offers the best chance for long-term survival. In select patients with locally advanced and unresectable SMN, reirradiation should be strongly considered as a curative option.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Overall survival in patients with radiation-related second malignant neoplasm (n = 235).
Figure 2
Figure 2. Overall survival according to treatment modalities of radiation-related second malignant neoplasm (n = 235).

Similar articles

Cited by

References

    1. Jia WH, Huang QH, Liao J, Ye W, Shugart YY et al. (2006) Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer 6: 178. doi:10.1186/1471-2407-6-178. PubMed: 16822324. - DOI - PMC - PubMed
    1. Palazzi M, Orlandi E, Bossi P, Pignoli E, Potepan P et al. (2009) Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience. Int J Radiat Oncol Biol Phys 74: 774-780. doi:10.1016/j.ijrobp.2008.08.068. PubMed: 19250771. - DOI - PubMed
    1. Tham IW, Hee SW, Yeo RM, Salleh PB, Lee J et al. (2009) Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy–the national cancer centre Singapore experience. Int J Radiat Oncol Biol Phys 75: 1481-1486. doi:10.1016/j.ijrobp.2009.01.018. PubMed: 19386431. - DOI - PubMed
    1. Lai SZ, Li WF, Chen L, Luo W, Chen YY et al. (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80: 661-668. doi:10.1016/j.ijrobp.2010.03.024. PubMed: 20643517. - DOI - PubMed
    1. Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91: 4-15. doi:10.1016/j.radonc.2008.12.016. PubMed: 19201045. - DOI - PubMed

Publication types

LinkOut - more resources